Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropicamide vs cyclopentolate for cycloplegia in 4–6-year-old children
2015-000268-32Phase 4Terminated
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tropicamide and cyclopentolate in cycloplegia, amblyopia and well-being (2 arms), sponsored by Universitätsklinikum Erlangen. Primary endpoint: Spheric equivalent of refraction after tropicamide vs. cyclopentolate. Started Jun 2015; status: terminated.
02
Drugs
tropicamidecyclopentolate
03
Conditions
cycloplegiaamblyopiawell-being
Beyond the preview
Go deeper on 2015-000268-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000268-32.